AMEND news in Month: June 2026

• AMEND Endorses Call for More Biomarker Information on Belzutifan

  

  Along with other patient groups and medical societies, AMEND has endorsed a group of clinicians and researchers who have submitted a detailed letter to the medical journal, Trends in Endocrinology & Metabolism, calling for more data from the clinical trial of Belzutifan to be released.

  Read more

• Successful Joint Patient Education Event

  

  On Saturday 6th June, AMEND joined forces with Neuroendocrine Cancer UK run a patient education event in Sheffield, under our Neuroendocrine Life Alliance collaborative working banner.  Over 100 people attended on the day along with the excellent speakers.  

  Read more

• Archived news
• 2026
• 2025
• 2024
• 2023
• 2022
• 2021
• 2020
• 2019
• 2018
• 2017
• 2016